Supriya Lifescience Limited - Company Profile

Q: Where is Supriya Lifescience Limited headquartered?

Supriya Lifescience Limited is headquartered at 207208, Udyog Bhavan, Sonawala Road, Goregaon East,, Mumbai, Maharashtra, 400063.

Q: Who are the current directors of Supriya Lifescience Limited?

The current directors of Supriya Lifescience Limited are Dileep Kumar Jain, Smita Satish Wagh, Neelam Yashpal Arora, Sunil Subhash Bhagwat, Shivani Satish Wagh, Saloni Satish Wagh, Krishna Raghunathan, Satish Waman Wagh, Dinesh Navnitlal Modi, Balasaheb Gulabrao Sawant, Ganapathi Dadasaheb Yadav, Prachi Suhas Sathe.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2008.

2008 Mumbai, Maharashtra, India Active

Last Updated: December 30, 2025

Access Report

About Supriya Lifescience Limited

Supriya Lifescience Limited, a active public limited company, was established on 26 March 2008 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L51900MH2008PLC180452. Registered under ROC Roc Mumbai. it is listed on BSE: 543434 and NSE: SUPRIYA. It has an authorized capital of ₹35.00 Cr and a paid-up capital of ₹16.10 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹581.01 Cr and a net worth of ₹815.37 Cr. Employing 450 professional, Its leadership includes Dileep Kumar Jain (Director), Smita Satish Wagh (Whole-Time Director), Neelam Yashpal Arora (Director). Past directors included Dileep Kumar Jain, Asha Waman Wagh, Smita Satish Wagh. It holds ₹262.41 Cr open charges and ₹169.96 Cr settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East),, Mumbai, Maharashtra, 400063.

Company Details

CIN/LLPIN
L51900MH2008PLC180452
Registration Number
180452
Incorporation Date
26 March 2008
Authorized Capital
₹35.00 Cr
Paid-Up Capital
₹16.10 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 543434, NSE: SUPRIYA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 35.00 Cr as on 30-12-2025
Paid Up Capital ₹ 16.10 Cr as on 30-12-2025
Company Age 17 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 262.41 Cr as on 30-12-2025
Satisfied Charges ₹ 169.96 Cr as on 30-12-2025
Revenue Growth **** 23.51% (FY 2024)
Profit Growth **** 32.56% (FY 2024)
Ebitda **** 34.21% (FY 2024)
Net Worth 16.57% (FY 2024)
Total Assets **** 12.31% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Supriya Lifescience Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Supriya Lifescience Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dileep Kumar Jain	Director	25 Mar 2021	Current
Smita Satish Wagh	Whole-Time Director	26 Mar 2008	Current
Neelam Yashpal Arora	Director	25 Mar 2021	Current
Sunil Subhash Bhagwat	Additional Director	24 Jan 2025	Current
Shivani Satish Wagh	Managing Director	01 Jul 2022	Current
Saloni Satish Wagh	Managing Director	01 Jul 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	02 Aug 2021	Past
Pramod Abcsdd	Whole-Time Director	31 May 2019	Past
Pramod Abcsdd	Whole-Time Director	31 May 2022	Past
Pramod Abcsdd	Director	24 Feb 2017	Past
Pramod Abcsdd	Additional Director	02 Aug 2021	Past
Pramod Abcsdd	Whole-Time Director	15 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supriya Lifescience.

Supriya Lifescience Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.51% increase. The company also saw a substantial improvement in profitability, with a 32.56% increase in profit. The company's net worth Soared by an impressive increase of 16.57%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

23.51%

*******

Revenue from Operations

*******

23.74%

*******

Total Assets

*******

12.31%

*******

Profit or Loss

*******

32.56%

*******

Net Worth

*******

16.57%

*******

EBITDA

*******

34.21%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supriya Lifescience?

In 2024, Supriya Lifescience had a promoter holding of 67.64% and a public holding of 32.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,624,102,000.00

Satisfied Charges

₹1,699,574,443.00

Charges Breakdown by Lending Institutions

Idbi Trusteeship Services Limited : 114.00 Cr
Others : 87.00 Cr
Axis Bank Limited : 44.00 Cr
The Saraswat Cooperative Bank Ltd : 12.91 Cr
The Saraswat Co-Op Bank Ltd : 4.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Jun 2025	Idbi Trusteeship Services Limited	₹114.00 Cr	Open
03 May 2024	Axis Bank Limited	₹44.00 Cr	Open
17 Apr 2024	Others	₹30.00 Cr	Open
05 Jul 2012	The Saraswat Cooperative Bank Ltd	₹2.00 Cr	Open
27 Jun 2009	The Saraswat Cooperative Bank Ltd	₹10.91 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Supriya Lifescience?

Supriya Lifescience has a workforce of 450 employees as of Apr 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Supriya Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Lifescience's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supriya Lifescience

Recent Activity within the Organization

Annual General Meeting

Progress on Supriya Lifescience Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was documented.
24 Sep 2025
Charges

The activity A charge with Idbi Trusteeship Services Limited amounted to Rs. 114.00 Cr with Charge ID 101126368 was registered on 26 Jun 2025. was completed.
26 Jun 2025
Balance Sheet

The activity Supriya Lifescience Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
31 Mar 2025
Director Appointment

Progress on Prachi Suhas Sathe was appointed as a Company Secretary was appointed as a Company Secretary on 17 Mar 2025 & has been associated with this company since 11 months 19 days . was documented.
17 Mar 2025
Director Appointment

Progress on Sunil Subhash Bhagwat was appointed as a Additional Director was appointed as a Additional Director on 24 Jan 2025 & has been associated with this company since 1 year 1 month . was documented.
24 Jan 2025
Director Appointment

Progress on Ganapathi Dadasaheb Yadav was appointed as a Additional Director was appointed as a Additional Director on 24 Jan 2025 & has been associated with this company since 1 year 1 month . was documented.
24 Jan 2025

Explore recent activity and updates - View Recent Activity